(4-NH2)-Exatecan |
| Catalog No.GC65358 |
(4-NH2)-Exatecan, 특허 US20200306243A1, 화합물 A에서 추출한 토포이소머라제 억제제 유도체. (4-NH2)-Exatecan은 항체-약물 접합체(ADC)의 합성에 사용할 수 있습니다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2495742-21-5
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
(4-NH2)-Exatecan, a topoisomerase inhibitor derivative extracted from patent US20200306243A1, compound A. (4-NH2)-Exatecan can be used in the synthesis of antibody-drug conjugates (ADCs)[1].
[1]. Howard PW, et, al. Compounds and conjugates thereof. US20200306243A1.
Review for (4-NH2)-Exatecan
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for (4-NH2)-Exatecan
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *